LPCAT1 and breast carcinoma: We found that the AGPAT9 was significantly decreased at mRNA level (–240.368-fold, P = 0.0006, Supplementary Figure S1A) in the drug-resistant breast cancer cell line MCF7/ADR than in the drug-sensitive breast cancer cell line MCF7.